GCCL, a leading South Korea-based provider of clinical trial sample analysis, and OPIS, a global full-service contract ...

Findings reinforce brilaroxazine’s treatment effect on negative symptoms and other symptom domains in schizophrenia and support ...

As clinical research evolves at an unprecedented pace, it’s important that physicians understand how emerging trends may ...

Optimising RSV sample handling and laboratory workflows to support faster, more efficient clinical trial delivery.

With the rise of biologics, precision medicine and AI-driven drug discovery, clinical research has entered a new and complex ...

LYON, France--(BUSINESS WIRE)--Regulatory News: PHAXIAM Therapeutics (Euronext: PHXM - FR0011471135), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial ...

Lexeo Therapeutics has posted updated data in Friedreich ataxia (FA) patients, linking a gene therapy to improvements on outcomes the biotech plans to use as co-primary endpoints in a registrational ...

SAN DIEGO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent ...

A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the studies’ key analyses, while also highlighting how an increase in clinical ...

CEO David Mazzo emphasized the company’s continued momentum despite market challenges, highlighting significant progress in advancing the clinical development of its lead product candidate, ...